JOHN F DINEEN
Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease LEXINGTON, KY NPI 1700810074
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease KY GENZYME CORPORATION All categories
General Payments — all program years on this page
$1,135.72
- Category: General Payments
- Program years: PY2018–2019
- Record count: 47
- As of (CMS publication): 2026-01-23
Latest program year (PY2019): $227.54 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2019) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $227.54 | 8 |
By paying entity
Latest program year (PY2019) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $111.14 | 1 |
| GlaxoSmithKline, LLC. | $40.43 | 3 |
| Mylan Specialty L.P. | $23.49 | 1 |
| Sunovion Pharmaceuticals Inc. | $20.41 | 1 |
| Acerta Pharma LLC | $16.77 | 1 |
| Circassia Inc. | $15.30 | 1 |
By program year
Records — PY2019 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 660212955 | Circassia Pharmaceuticals Inc | $15.30 | 11/04/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 670306839 | GlaxoSmithKline, LLC. | $15.40 | 09/26/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 671099067 | GlaxoSmithKline, LLC. | $11.95 | 01/02/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 671496315 | GlaxoSmithKline, LLC. | $13.08 | 01/03/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 685606761 | AstraZeneca Pharmaceuticals LP | $16.77 | 04/26/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 688014625 | Sunovion Pharmaceuticals Inc. | $20.41 | 06/11/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 694067815 | GENZYME CORPORATION | $111.14 | 05/14/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 694778901 | Mylan Specialty L.P. | $23.49 | 04/02/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.